10/19/2026
Danny Malone returns with 'Burning Hills' after ibogaine treatment
Singer-songwriter Danny Malone's new album follows recovery from addiction with ibogaine therapy.
Topic archive
opioid use disorder
50 stories
10/19/2026
FDA seeks input on ibogaine trial design, advances psychedelic framework
FDA's request for ibogaine trial input marks a step in psychedelic drug regulation.
10/16/2026
Lilly explores ibogaine research opportunities
Pharmaceutical giant Lilly shows interest in advancing ibogaine studies.
10/14/2026
Ibogaine's potential in addiction treatment faces cardiac risks
New review highlights ibogaine's promise and dangers in addiction therapy.
10/9/2026
FDA seeks public input on ibogaine trials
Gabon aims to secure benefits from rising ibogaine demand
10/9/2026
Ibogaine clinical trials: design and safety insights
Exploring safety and design in ibogaine trials for opioid use disorder.
9/21/2026
Presley Gerber's ibogaine treatment in Mexico before death
Model Presley Gerber underwent ibogaine therapy in Cancun months before his passing.
9/21/2026
Presley Gerber's death highlights ibogaine treatment
Model's passing at 27 raises questions about ibogaine's role in addiction recovery.
9/18/2026
Ibogaine treatment marks 22 years in addiction therapy
David Dardashti's ibogaine program celebrates milestone in addiction treatment innovation.
9/17/2026
ARPA-H ibogaine workshop emphasizes precision
ARPA-H workshop explores ibogaine's potential with a focus on precision.
9/11/2026
Ibogaine's potential in opioid addiction treatment
Ibogaine offers a novel approach to opioid detox, but carries significant risks.
9/10/2026
Rhelion Life Sciences launches ibogaine stability program
Filament Health begins stability program for IBEX011 amid rising ibogaine demand.
9/10/2026
Filament Health plans stability program for ibogaine drug
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/26/2026
University of Miami gifts 1994 ibogaine IND to HHS
The move promotes open science and could influence future psychedelic research.
8/21/2026
University of Miami gifts ibogaine application to Trump admin
The move could expedite psychedelic research for veteran treatment.
8/21/2026
Ibogaine treatment footage released amid therapy push
David Dardashti shares clinical footage as psychedelic therapy gains federal interest.
8/19/2026
Psyence Biomedical stock rises 27% on ibogaine research
Market optimism grows as Psyence Biomedical advances ibogaine studies.
8/19/2026
Trump emphasizes ibogaine development, Psyence BioMed reacts
Former President Trump supports ibogaine research, sparking industry response.
8/19/2026
Psyence BioMed backs Trump ibogaine initiative
Company aligns with U.S. efforts to advance ibogaine research.
8/19/2026
Trump highlights ibogaine research in executive order
Ibogaine, a psychedelic drug, gains federal attention for treating addiction.
8/19/2026
University of Miami submits ibogaine application to federal authorities
Trump announces transfer of ibogaine investigational drug application to accelerate research.
8/16/2026
Ibogaine shows promise for treating brain disorders
Research highlights ibogaine's potential in opioid addiction and multiple sclerosis.
8/15/2026
Ibogaine offers new hope for kratom users amid bans
David Dardashti advocates ibogaine as a medical solution for kratom dependency.
8/13/2026
Ibogaine gains attention as Trump discusses potential
Former President Trump highlights ibogaine in discussions on addiction.
8/12/2026
Ibogaine treatment: brain effects explored
NBC 7 San Diego video delves into ibogaine's impact on the brain.
8/12/2026
UC Irvine explores ibogaine's impact on the brain
NBC San Diego reports on UC Irvine's ibogaine research and patient recovery.
8/10/2026
Ibogaine trials for opioid use disorder get ARPA-H boost
ARPA-H seeks to accelerate ibogaine trials for opioid treatment
8/8/2026
SAMHSA gathers experts on psychedelics
AtaiBeckley and Compass Pathways explore new opportunities.
8/7/2026
Ibogaine gains traction among conservative leaders
Rick Perry and Bryan Hubbard lead efforts to legitimize ibogaine in Texas.
8/6/2026
Ibogaine-related death under investigation in Cambridge
Police probe follows death linked to unauthorized ibogaine use in Canada.
8/5/2026
Ibogaine research review highlights safety concerns
Thirty years of ibogaine studies reveal potential but highlight risks.
8/5/2026
Ibogaine death in Cambridge prompts police warning
Police charge Mississauga man after ibogaine-related death, highlighting risks.
7/31/2026
Ibogaine research gains momentum in Mississippi
Mississippi explores ibogaine trials for addiction treatment, reflecting a shift towards health-centered drug policies.
7/30/2026
Scottsdale Research Institute submits new ibogaine IND
The institute seeks approval to study ibogaine's potential in treating addiction.
7/29/2026
Ibogaine research faces representation challenges
Psychedelic trials often exclude marginalized groups, raising questions about equity and efficacy.
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas receives federal funding, advancing research into opioid treatment.
7/29/2026
Scottsdale Research Institute submits IND for ibogaine
Ibogaine HCl aims to treat PTSD, TBI, and opioid use disorder.
7/29/2026
Texas initiates ibogaine research with federal support
State-led ibogaine study in Texas gains federal backing, marking a significant research development.
7/28/2026
Ibogaine inquiries on YouTube spark interest
YouTube video explores ibogaine's potential in treating disorders.
7/24/2026
Heidi Overton's role in Trump's ibogaine policy
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.
7/24/2026
Trump administration fast-tracks ibogaine research
Ibogaine research gains momentum under Trump administration's expedited process.
7/24/2026
Experience Ibogaine supports 3,000 patients in recovery
The Tijuana-based center marks a milestone in ibogaine treatment for substance use disorder.
7/24/2026
Ibogaine may gain U.S. access under Trump administration
The Trump administration considers making ibogaine available for therapeutic use.
7/23/2026
Trump administration considers ibogaine for addiction treatment
Ibogaine, a psychedelic, eyed for opioid crisis intervention under Trump.
7/23/2026
McCaul supports NDAA amendment for veteran ibogaine access
The amendment aims to expand treatment options for PTSD and addiction.
7/23/2026
Ibogaine research and inquiries on YouTube
YouTube video explores ibogaine's potential in treating addiction.
7/22/2026
McCaul advocates for ibogaine access for veterans
Proposed NDAA amendment aims to expand treatment options for PTSD and TBI.
7/16/2026
Texas leaders advocate ibogaine research
Veterans report transformative effects from psychedelic therapy.
7/16/2026
Texas leaders advocate for ibogaine research
Veterans share recovery stories, highlighting ibogaine's potential.
7/15/2026
HHS and VA collaborate to advance psychedelic therapy
New agreement includes ibogaine research for opioid use disorder.